SCHEMBL19660419

SCHEMBL19660419

Cc1cccc2c(CO)cncc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.44
CYP2A6 P11509 2/20 0.44
ALDH1A1 P00352 2/20 0.39
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
CYP19A1 P11511 2/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34
CYP2C19 P33261 1/20 0.34
CASP7 P55210 1/20 0.34
HIF1A Q16665 1/20 0.34
ATP4A P20648 1/20 0.34
ATP4B P51164 1/20 0.34
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19660438 0.85 CYP2A6 (0.44) CYP1A2CYP2A6ALDH1A1CYP19A1LMNA
SCHEMBL11319820 0.82 KDM4E (0.40) CYP1A2CYP2A6PDCD1CD274CYP19A1
SCHEMBL8404557 0.77 CYP1A2 (0.62) CYP1A2CYP2A6ALDH1A1TSHRCYP11B1
SCHEMBL19660439 0.77 EGLN1 (0.36) CYP1A2CYP3A4CYP2D6CYP2C9CASP1
SCHEMBL21237270 0.77 CA2 (0.39) CYP1A2ALDH1A1CYP19A1CYP3A4CYP2D6
SCHEMBL19660415 0.76 HASPIN (0.36) CYP1A2ALDH1A1CYP19A1MEN1KMT2A
SCHEMBL18495615 0.76 KMT2A (0.40) CYP1A2CYP2A6ALDH1A1PDCD1CD274
SCHEMBL13765864 0.72 CYP1A2 (0.48) CYP1A2CYP2A6ALDH1A1CYP11B1CYP11B2
SCHEMBL19663002 0.72 CYP1A2 (0.48) CYP1A2CYP2A6ALDH1A1MEN1KMT2A
SCHEMBL19953988 0.72 CYP1A2 (0.48) CYP1A2CYP2A6ALDH1A1TSHRCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464286-B1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2021-08-18 EP disclosed
WO-2017205538-A1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH, INC. (US) 2017-11-30 WO disclosed